Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

Qualification and Oversight in Decentralized Trials: Practical Considerations for Clinical Operations and Quality Oversight

Session Chair(s)

Dennis  Salotti, MBA, MS

Dennis Salotti, MBA, MS

Senior Director and Head of Strategic Outsourcing and Clinical Innovation

Jazz Pharmaceuticals , United States

In this interactive panel discussion, we will explore the critical role that providers, sponsors, and collaboratives play in driving greater adoption of decentralized clinical trials (DTs). Attendees are encouraged to engage in the discussion.

Learning Objective : Define familiarity with the use of technologies and approaches enabling DTs; Identify challenges of vendor qualification for DTs versus traditional trials; Describe key risks when qualifying DT service providers; Characterize change management elements of success and how providers can support this effort; Describe role collaboratives and standards play in facilitating broader adoption of DTs.

Speaker(s)

Alison  Holland

Panelist

Alison Holland

Medable, United States

Executive General Manager, Digital and Decentralized Solutions

Heather  Zigmund, PharmD

Qualification and Oversight in Decentralized Trials: Practical Considerations for Clinical Operations and Quality Oversight

Heather Zigmund, PharmD

AstraZeneca, United States

Senior Director, Global Head of Study Management Early Stage Development BioPhar

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.